Michael Munin
Specialist
- Medicare participating
At a glance
- Years since graduation
- 38
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 157
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Specialist primary
PA license MD043854L
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UPMC Presbyterian Shadyside Pittsburgh, PA
Medical groups
- University of Pittsburgh Physicians (4,236 clinicians)
- Mrs Physical Therapy (182 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 157
- Services billed
- 49,215
- Patients’ average age
- 66
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 23,531 | 25 |
| Injection, incobotulinumtoxin a, 1 unit | 8,350 | 14 |
| Injection, abobotulinumtoxina, 5 units | 6,640 | 15 |
| Ultrasonic guidance for needle placement | 117 | 52 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 76 | 34 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 65 | 52 |
| Established patient office or other outpatient visit, 20-29 minutes | 45 | 32 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 30 | 14 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 27 | 13 |
| Nerve conduction, 13 or more studies | 20 | 20 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 13 payments worth $11,610 in total to this clinician.
| AbbVie Inc. | $11,455 |
|---|---|
| Pacira Pharmaceuticals Incorporated | $123 |
| E.r. Squibb & Sons, L.l.c. | $32.22 |
| Consulting Fee | $10,800 |
|---|---|
| Food and Beverage | $415 |
| Travel and Lodging | $396 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. Mar 3, 2025 | Consulting Fee | $8,775 |
| AbbVie Inc. Dec 18, 2025 | Consulting Fee | $2,025 |
| AbbVie Inc. Feb 6, 2025 | Travel and Lodging travel to IRVINE, CA · in-kind Company’s descriptionM25-076 | $253 |
| AbbVie Inc. Mar 3, 2025 | Travel and Lodging travel to IRVINE, CA · in-kind | $143 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 4 companies. The companies reported $47,038 in research payments for these studies, mostly to the institutions running them.
- A Multicenter, Randomized, Double-Blind, Sham-Controlled Study Assessing the Efficacy and Safety of iovera®° system in Subjects with Upper Extremity Spasticity
Pacira Pharmaceuticals Incorporated - M21-471 - Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor
AbbVie Inc. - Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor
AbbVie Inc. · Completed · NCT05216250 - Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of NT 201 in the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury in Adu…
Merz Pharmaceuticals, LLC - A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
Ipsen Pharma Sas · Completed · NCT04936542
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.